Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AR7 是一种非典型的 RARA/RARα(视黄酸受体 α) 拮抗剂,能够特异性激活伴侣介导的自噬活性,对自噬无影响。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 217 | 现货 | ||
5 mg | ¥ 477 | 现货 | ||
10 mg | ¥ 822 | 现货 | ||
25 mg | ¥ 1,730 | 现货 | ||
50 mg | ¥ 2,950 | 现货 | ||
100 mg | ¥ 4,350 | 现货 | ||
200 mg | ¥ 6,150 | 现货 | ||
500 mg | ¥ 9,120 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 538 | 现货 |
产品描述 | AR7 is a retinoic acid receptor α (RARα) antagonist. |
体外活性 | Chaperone-mediated autophagy (CMA) contributes to cellular quality control and the cellular response to stress through the selective degradation of cytosolic proteins in lysosomes. Decrease in CMA activity occurs in aging and in age-related disorders. Signaling through the retinoic acid receptor alpha (RARα) inhibits CMA. AR7, an RARα antagonist, significantly activates CMA activity in mouse fibroblasts. A marked increase in CMA-activating potency is found when AR7 and GR1 are combined, supporting their cooperative effect. Treatment with the transcriptional repressor Actinomycin D partially reduces the stimulatory effect of AR7 on CMA, consistent with transcriptional changes contributing to the upregulation of CMA. The antagonistic effect of the retinoid derivatives likely results from a combination of tight binding to RARα and high stability. |
分子量 | 257.71 |
分子式 | C15H12ClNO |
CAS No. | 80306-38-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5.5 mg/mL (21.34 mM), Sonification is recommended
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.8803 mL | 19.4017 mL | 38.8033 mL | 97.0083 mL |
5 mM | 0.7761 mL | 3.8803 mL | 7.7607 mL | 19.4017 mL | |
10 mM | 0.388 mL | 1.9402 mL | 3.8803 mL | 9.7008 mL | |
20 mM | 0.194 mL | 0.9701 mL | 1.9402 mL | 4.8504 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
AR7 80306-38-3 Metabolism Retinoid Receptor receptor CMA Retinoid X receptors Retinoic acid receptors retinoic macroautophagy AR-7 inhibit acid RAR/RXR Inhibitor AR 7 inhibitor